Lazard International Strategic Equity Portfolio

30 ROCKEFELLER PLAZA,
NEW YORK , NY, 10112

Rank

Rank Universe

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team focuses on securities of non-US companies that are estimated to trade below their fai More

Link

Directors

Mar 5, 2024
  • Robert M. Solmson
  • Kenneth S. Davidson
  • Trevor W. Morrison
  • Evan L. Russo
  • Franci J. Blassberg
  • Richard Reiss, Jr.
  • Nancy A. Eckl
  • Nathan A. Paul

Chief Compliance Officer

  • Nargis Hilal

Fund Manager(s)

Price

  • $ 13.78 ( +0.07 )
    Jan 17, 2025
    Last Close
  • Net Assets
  • $4.4B
    Feb 26, 2024
  • Holding
  • 63
    Aug 20, 2024
    More

  • 52-Week High/Low
  • $16.96 - $13.39
  • Turnover
  • 32.3%
  • Expense Ratio
  • 0.82%

Company Name

Holding

Novo Nordisk A/S 5.46 %
ASML Holding NV 4.32 %
RELX PLC 3.3 %
ICON PLC 2.81 %
Siemens AG 2.44 %
Aon PLC 2.36 %
Coca-Cola Europacific Partners PLC 2.32 %
ABB Ltd 2.2 %
Accenture PLC 2.16 %
Airbus SE 2.11 %
More 2.11 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

2.61%

5 Year

-12.4%

Best

27.83%

2017

Worst

-18.01%

2022

Alpha

RLITX S&P 500

Chart +